Literature DB >> 8174614

Depressive effects of arenobufagin on the delayed rectifier K+ current of guinea-pig cardiac myocytes.

J dos S Cruz1, H Matsuda.   

Abstract

The effects of a bufadienolide isolated from toad venom, arenobufagin, a potent Na+/K+ pump inhibitor, were studied in single guinea-pig ventricular cells in the whole-cell patch-clamp configuration. Arenobufagin (50 microM) applied extracellularly decreased the amplitude of the delayed rectifier K+ current (IdK) by 30% without affecting the gating kinetics. The L-type Ca2+ current was also depressed, but to a lesser extent. The inward rectifier K+ current was hardly affected. Ouabain and the internal dialysis of cells with the solution containing 20 mM Na+ depressed IdK in a similar way as arenobufagin. On the other hand, arenobufagin also depressed IdK when the Na+/K+ pump was already inhibited in the K(+)-free Tyrode solution. Therefore, both a direct effect on the channel and an indirect effect through the inhibition of the Na+/K+ pump may be involved in the depression of IdK by arenobufagin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174614     DOI: 10.1016/0922-4106(94)90142-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Effect of arenobufagin on human pancreatic carcinoma cells.

Authors:  Tianjiao Wang; Zhumei Zhuang; Peng Zhang; Yueyue Wang; Lin Mu; Haifeng Jin; Lei Zhou; Xiaochi Ma; Rui Liang; Yuhui Yuan
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

2.  Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.

Authors:  Aline Lara; Denis D Damasceno; Rita Pires; Robert Gros; Enéas R Gomes; Mariana Gavioli; Ricardo F Lima; Diogo Guimarães; Patricia Lima; Carlos Roberto Bueno; Anilton Vasconcelos; Danilo Roman-Campos; Cristiane A S Menezes; Raquel A Sirvente; Vera M Salemi; Charles Mady; Marc G Caron; Anderson J Ferreira; Patricia C Brum; Rodrigo R Resende; Jader S Cruz; Marcus Vinicius Gomez; Vania F Prado; Alvair P de Almeida; Marco A M Prado; Silvia Guatimosim
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

3.  The effects of bufadienolides on HER2 overexpressing breast cancer cells.

Authors:  Tianjiao Wang; Lin Mu; Haifeng Jin; Peng Zhang; Yueyue Wang; Xiaochi Ma; Jinjin Pan; Jian Miao; Yuhui Yuan
Journal:  Tumour Biol       Date:  2015-12-12

4.  Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.

Authors:  Qingxi Yue; Hong Zhen; Ming Huang; Xi Zheng; Lixing Feng; Baohong Jiang; Min Yang; Wanying Wu; Xuan Liu; Dean Guo
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

5.  Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.

Authors:  Li-Juan Deng; Qun-Long Peng; Long-Hai Wang; Jun Xu; Jun-Shan Liu; Ying-Jie Li; Zhen-Jian Zhuo; Liang-Liang Bai; Li-Ping Hu; Wei-Min Chen; Wen-Cai Ye; Dong-Mei Zhang
Journal:  Oncotarget       Date:  2015-10-27

6.  Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles.

Authors:  Xue Yuan; Qian Xie; Keyu Su; Zhijie Li; Dong Dong; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2017-07-12

7.  Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.

Authors:  Liang Ma; Yindi Zhu; Sheng Fang; Hongyan Long; Xiang Liu; Zi Liu
Journal:  Molecules       Date:  2017-09-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.